Subtopic Deep Dive

← Medicinal Plants and Bioactive Compounds

Salidroside Pharmacology
Research Guide

What is Salidroside Pharmacology?

Salidroside pharmacology studies the pharmacokinetics, bioavailability, molecular targets, and therapeutic effects of salidroside, a bioactive compound from Rhodiola species.

Salidroside exhibits anti-apoptotic, anti-inflammatory, and Nrf2 activation properties (Zhang et al., 2021, 192 citations). Research covers its neuroprotective roles via PI3K/AKT pathways and stress-protective adaptogen activity (Panossian and Wikman, 2010, 236 citations; Zhong et al., 2018, 131 citations). Over 10 key papers from 2008-2021 document these mechanisms, with 443 citations for top PI3K/AKT review.

Curated Papers

Key Challenges

Why It Matters

Salidroside targets PI3K/AKT pathways to prevent Alzheimer's and Parkinson's, offering leads for neurodegenerative drug development (Long et al., 2021). It enhances stress resistance and lifespan in C. elegans models, supporting adaptogen applications in mood disorders and sports performance (Wiegant et al., 2008; Qureshi and Al-Bedah, 2013; Sellami et al., 2018). Nrf2 activation by salidroside protects against ischemic stroke, with potential in COVID-19 adjunct therapy (Liu et al., 2019; Ni et al., 2020). These effects bridge traditional Rhodiola use to modern pharmacology (Panossian and Wikman, 2010; Cui et al., 2015).

Key Research Challenges

Low Oral Bioavailability

Salidroside shows poor absorption and rapid metabolism, limiting systemic efficacy (Zhang et al., 2021). Studies highlight need for nano-formulations or prodrugs. No high-citation paper resolves delivery fully.

Mechanism Specificity Gaps

PI3K/AKT and Nrf2 pathways overlap with off-target effects unclear (Long et al., 2021; Liu et al., 2019). Zhong et al. (2018) detail CNS actions but lack isoform selectivity data. Clinical translation stalls without precise targets.

Dose-Response Variability

Adaptogen effects vary by stress model and species, from C. elegans to rats (Wiegant et al., 2008; Panossian and Wikman, 2010). Human trials absent; toxicity profiles incomplete (Zhong et al., 2018).

Essential Papers

PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer’s Disease and Parkinson’s Disease

Hui‐Zhi Long, Yan Cheng, Ziwei Zhou et al. · 2021 · Frontiers in Pharmacology · 443 citations

Alzheimer’s disease (AD) and Parkinson’s disease (PD) are two typical neurodegenerative diseases that increased with aging. With the emergence of aging population, the health problem and economic b...

Effects of Adaptogens on the Central Nervous System and the Molecular Mechanisms Associated with Their Stress—Protective Activity

Alexander Panossian, G. Wikman · 2010 · Pharmaceuticals · 236 citations

Adaptogens were initially defined as substances that enhance the “state of nonspecific resistance” in stress, a physiological condition that is linked with various disorders of the neuroendocrine-i...

Salidroside: A review of its recent advances in synthetic pathways and pharmacological properties

Xumin Zhang, Long Xie, Jiaying Long et al. · 2021 · Chemico-Biological Interactions · 192 citations

Plant adaptogens increase lifespan and stress resistance in C. elegans

F. A. C. Wiegant, S. Surinova, E. Ytsma et al. · 2008 · Biogerontology · 185 citations

Combating COVID-19 with integrated traditional Chinese and Western medicine in China

Liqiang Ni, Lili Chen, Xia Huang et al. · 2020 · Acta Pharmaceutica Sinica B · 183 citations

COVID-19, an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread throughout the world. China has achieved rapid containment of this highly infectio...

Herbal medicine for sports: a review

Maha Sellami, Olfa Slimeni, Andrzej Pokrywka et al. · 2018 · Journal of the International Society of Sports Nutrition · 171 citations

<i>The use of herbal medicinal products and supplements has increased</i> during last decades. At present, some herbs are used to enhance muscle strength and body mass. Emergent evidence suggests t...

Critical Role of Nrf2 in Experimental Ischemic Stroke

Lei Liu, Logan M. Locascio, Sylvain Doré · 2019 · Frontiers in Pharmacology · 151 citations

Ischemic stroke is one of the leading causes of death and long-term disability worldwide; however, effective clinical approaches are still limited. The transcriptional factor Nrf2 is a master regul...

Reading Guide

Foundational Papers

Start with Panossian and Wikman (2010, 236 citations) for adaptogen mechanisms and stress-protective activity; Wiegant et al. (2008, 185 citations) for lifespan data in C. elegans models.

Recent Advances

Study Zhang et al. (2021, 192 citations) for pharmacology/synthesis advances; Long et al. (2021, 443 citations) for PI3K/AKT in neurodegeneration; Zhong et al. (2018) for CNS specifics.

Core Methods

Core techniques: cell viability MTT assays, Western blots for Nrf2/PI3K, C. elegans stress models, and HPLC for pharmacokinetics (Zhong et al., 2018; Liu et al., 2019; Wiegant et al., 2008).

How PapersFlow Helps You Research Salidroside Pharmacology

Discover & Search

Research Agent uses searchPapers('salidroside Nrf2 activation') to find Liu et al. (2019), then citationGraph reveals 151 citing papers on stroke protection, and findSimilarPapers expands to PI3K/AKT targets from Long et al. (2021). exaSearch queries 'salidroside bioavailability formulations' for recent analogs.

Analyze & Verify

Analysis Agent applies readPaperContent on Zhang et al. (2021) to extract pharmacokinetic data, verifyResponse with CoVe cross-checks Nrf2 claims against Panossian and Wikman (2010), and runPythonAnalysis plots dose-response curves from Zhong et al. (2018) data using matplotlib. GRADE grading scores evidence as moderate for neuroprotection.

Synthesize & Write

Synthesis Agent detects gaps in bioavailability studies across papers, flags contradictions in adaptogen definitions (Panossian vs. Wiegant), and uses exportMermaid for PI3K/AKT pathway diagrams. Writing Agent employs latexEditText for methods sections, latexSyncCitations for 10+ references, and latexCompile to generate a review manuscript.

Use Cases

"Extract dose-response data from salidroside neuroprotection papers and plot IC50 curves"

Research Agent → searchPapers → Analysis Agent → readPaperContent (Zhong et al., 2018) → runPythonAnalysis (pandas curve fitting, matplotlib plots) → researcher gets CSV of fitted parameters and publication-ready figures.

"Write LaTeX review on salidroside Nrf2 mechanisms with citations and pathway figure"

Synthesis Agent → gap detection → Writing Agent → latexEditText (intro/methods) → latexSyncCitations (Liu et al., 2019; Long et al., 2021) → exportMermaid (Nrf2 diagram) → latexCompile → researcher gets PDF manuscript.

"Find GitHub repos analyzing salidroside C. elegans lifespan data"

Research Agent → searchPapers (Wiegant et al., 2008) → Code Discovery: paperExtractUrls → paperFindGithubRepo → githubRepoInspect → researcher gets annotated code for stress resistance models.

Automated Workflows

Deep Research workflow runs searchPapers on 'salidroside pharmacology' yielding 50+ papers, structures report with GRADE-scored sections on pharmacokinetics and targets (Zhang et al., 2021). DeepScan applies 7-step CoVe to verify adaptogen claims from Panossian and Wikman (2010) against recent citations. Theorizer generates hypotheses on salidroside-PI3K/AKT synergies for AD/PD from Long et al. (2021).

Try Doxa for Salidroside Pharmacology Research

Frequently Asked Questions

What is salidroside pharmacology?

Salidroside pharmacology examines pharmacokinetics, bioavailability, and effects like Nrf2 activation and neuroprotection from Rhodiola (Zhang et al., 2021; Zhong et al., 2018).

What are key methods in salidroside research?

Methods include C. elegans lifespan assays (Wiegant et al., 2008), PI3K/AKT pathway inhibition (Long et al., 2021), and Nrf2 reporter gene assays (Liu et al., 2019).

What are top papers on salidroside?

Zhang et al. (2021, 192 citations) reviews synthesis/pharmacology; Panossian and Wikman (2010, 236 citations) details adaptogen mechanisms; Zhong et al. (2018, 131 citations) covers CNS activities.

What open problems exist?

Challenges include improving bioavailability, clarifying target specificity beyond PI3K/AKT/Nrf2, and validating human doses absent in current literature (Zhang et al., 2021; Long et al., 2021).